Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Hypertension (Dallas, Tex. : 1979)|September 14, 2020
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical SuccessKang-Yung Peng, Hung-Wei Liao, Chieh-Kai Chan, et al.
Endocrine-Related Cancer|November 25, 2021
Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronismJui-Hsiang Lin, Kang-Yung Peng, Yu-Ping Kuo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing AdenomasKang-Yung Peng, Huang-Ming Chang, Yu-Feng Lin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 9, 2022
New-onset diabetes mellitus risk associated with concurrent autonomous cortisol secretion in patients with primary aldosteronismVin-Cent Wu, Chieh-Kai Chan, Wan-Chen Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2022
Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular OutcomesVin-Cent Wu, Kang-Yung Peng, Ya-Hui Hu, et al.
Scientific Reports|January 20, 2017
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomesVin-Cent Wu, Shuo-Meng Wang, Shih-Chieh Jeff Chueh, et al.
Scientific Reports|June 13, 2015
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese populationVin-Cent Wu, Kuo-How Huang, Kang-Yung Peng, et al.
Frontiers in Endocrinology|March 23, 2023
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronismYi-Yao Chang, Bo-Ching Lee, Zheng-Wei Chen, et al.
Antioxidants & Redox Signaling|August 2, 2013
Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitorGuang-Huar Young, Tao-Min Huang, Che-Hsiung Wu, et al.
Pageof 5